Recent Posts
- Booster l’efficacité des thérapies cellulaires
- LSX – Investival Showcase
- EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
- Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies
- Priothera cleared to begin Japanese arm of pivotal Phase 3 study with mocravimod in patients with Acute Myeloid Leukemia undergoing allogeneic Hematopoietic Cell Transplant
Recent Comments